Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care.
Saved in:
| Title: | Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care. |
|---|---|
| Authors: | Frol S; Department of Vascular Neurology, University Medical Centre Ljubljana, Zaloška 2, 1000, Ljubljana, Slovenia. senta.frol@kclj.si.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. senta.frol@kclj.si., Zupan M; Department of Vascular Neurology, University Medical Centre Ljubljana, Zaloška 2, 1000, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Šabovič M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Department of Vascular Disorders, University Medical Center Ljubljana, Ljubljana, Slovenia., Kermer P; Department of Neurology, University Medical Center, Göttingen, Germany.; Department of Neurology, Friesland Kliniken GmbH, Sande, Germany., Siddiqui AH; Jacobs Institute, SUNY University at Buffalo and Kaleida Health, Buffalo, NY, USA., Levy EI; Jacobs Institute, SUNY University at Buffalo and Kaleida Health, Buffalo, NY, USA. |
| Source: | CNS drugs [CNS Drugs] 2026 Jun; Vol. 40 (6), pp. 733-736. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42020835 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Frol+S%22">Frol S</searchLink>; Department of Vascular Neurology, University Medical Centre Ljubljana, Zaloška 2, 1000, Ljubljana, Slovenia. senta.frol@kclj.si.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. senta.frol@kclj.si.<br /><searchLink fieldCode="AU" term="%22Zupan+M%22">Zupan M</searchLink>; Department of Vascular Neurology, University Medical Centre Ljubljana, Zaloška 2, 1000, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Šabovič+M%22">Šabovič M</searchLink>; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Department of Vascular Disorders, University Medical Center Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Kermer+P%22">Kermer P</searchLink>; Department of Neurology, University Medical Center, Göttingen, Germany.; Department of Neurology, Friesland Kliniken GmbH, Sande, Germany.<br /><searchLink fieldCode="AU" term="%22Siddiqui+AH%22">Siddiqui AH</searchLink>; Jacobs Institute, SUNY University at Buffalo and Kaleida Health, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Levy+EI%22">Levy EI</searchLink>; Jacobs Institute, SUNY University at Buffalo and Kaleida Health, Buffalo, NY, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2026 Jun; Vol. 40 (6), pp. 733-736. – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42020835 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40263-026-01291-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 733 Titles: – TitleFull: Andexanet Alfa Withdrawn from the US: Implications for Intracranial Hemorrhage Care. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Frol S – PersonEntity: Name: NameFull: Zupan M – PersonEntity: Name: NameFull: Šabovič M – PersonEntity: Name: NameFull: Kermer P – PersonEntity: Name: NameFull: Siddiqui AH – PersonEntity: Name: NameFull: Levy EI IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1934 Numbering: – Type: volume Value: 40 – Type: issue Value: 6 Titles: – TitleFull: CNS drugs Type: main |
| ResultId | 1 |